BackLiminatus Pharma Warrants Overview

Liminatus Pharma Warrants Current Assets

Track Liminatus Pharma Warrants's current assets ($3.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$3.39M
↑ 90.34% YoYΔ $1.61M vs prior year quarter

Peer trimmed avg / median

Loading

Liminatus Pharma Warrants Current Assets History

Loading

Liminatus Pharma Warrants vs. peers: Current Assets Comparison

Loading

Liminatus Pharma Warrants Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Liminatus Pharma Warrants (LIMNW) FAQ

Liminatus Pharma Warrants (LIMNW) currently reports a current assets of $3.4M as of June 2026. That compares with $1.8M in the prior-year period — up 90.3% year over year. Use the charts on this page to explore Liminatus Pharma Warrants's current assets history and peer comparisons.

Liminatus Pharma Warrants's current assets increased from $1.8M to $3.4M — a 90.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Liminatus Pharma Warrants reported $3.4M in current assets as of June 2026. That compares with $1.8M in the prior-year period — up 90.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $3.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Liminatus Pharma Warrants, and consider following LIMNW for alerts when major investors trade the stock.